Nearly three dozen companies worldwide will soon start making generic versions of Pfizer’s coronavirus pill, the U.N.-backed Medicines Patent Pool that negotiated the deal says.

Join The Ecosystem

Leave a Reply

{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}